Successful treatment of choroidal neovascularization secondary to sorsby fundus dystrophy with intravitreal bevacizumab

Retinal Cases and Brief Reports

Volumn 5, Issue 2, 2011, Pages 132-135

  Gemenetzi, Maria K ^a   Luff, Andrew J ^a   Lotery, Andrew J ^a,b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Bevacizumab; CNV; Sorsby choroidal dystrophy

Indexed keywords

EID: 84856409039     PISSN: 19351089     EISSN: 19371578     Source Type: Journal    
DOI: 10.1097/ICB.0b013e3181cc216b     Document Type: Article

References (9)

1. Langton KP, McKie N, Smith BM, Brown NJ, Barker MD. Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells. Hum Mol Genet 2005;14: 3579-3586. (Pubitemid 41754659)
2. Qi JH, Ebrahem Q, Moore N, et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003;9:407-415. (Pubitemid 36460074)
3. Sorsby A, Joll Mason ME, Gardener N. A fundus dystrophy with unusual features (late onset and dominant inheritance of a central retinal lesion showing oedema, haemorrhage and exudates developing into generalised choroidal atrophy with massive pigment proliferation). Br J Ophthalmol 1949;33:67-97.
4. Prager F, Michels S, Geitzenauer W, et al. Choroidal neovascularization secondary to Sorsby fundus dystrophy treated with systemic bevacizumab (Avastin). Acta Ophthalmol Scand 2007;85:904-906. (Pubitemid 350142818)
5. Weber BHF, Vogt G, Pruett RC, et al. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 1994;8:352-356. (Pubitemid 24375600)
6. Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one year results of 2 randomized clinical trials TAP report. Treatment of age related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol 1999;117:1329-1345. (Pubitemid 30029343)
7. Holz FG, Haimovici R, Wagner DG, Bird AC. Recurrent choroidal neovascularization after laser photocoagulation in Sorsby's fundus dystrophy. Retina 1994;14:329-334. (Pubitemid 24310150)
8. Wong SC, Fong KCS, Lee N, et al. Successful photodynamic therapy for subretinal neovascularisation due to Sorsby's fundus dystrophy: 1 year follow up. Br J Ophthalmol 2003;87:796-797. (Pubitemid 36649247)
9. Schmidt-Erfurth U, Michels S, Barbazetto I, Laqua H. Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci 2002;43: 830-841. (Pubitemid 34184504)